Amylyx Pharmaceuticals (AMLX) Share-based Compensation (2021 - 2026)
Amylyx Pharmaceuticals' Share-based Compensation was $8.32 million in Q2 2026, up 13.2% from $7.35 million a year earlier and up 35.9% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Share-based Compensation (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amylyx Pharmaceuticals' Share-based Compensation was $27.9 million through Jun 30, 2026, up 0.6% year-over-year; for FY2025, it came in at $27.65 million, down 16.3% from FY2024.
- Share-based Compensation shows a four-year compound annual growth rate of 72.3% (FY2021 to FY2025).
- In earlier years, Share-based Compensation was $33.04 million in FY2024 (-11.1%), $37.16 million in FY2023 (+71.1%), $21.71 million in FY2022 (+592.4%) and $3.14 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Share-based Compensation since Q2 2024.
- Compared with a year earlier, Share-based Compensation was higher in two of the last eight quarters, with an average decline of 14.4%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2022 (growth of 768.6%); the worst was Q3 2024 (a decline of 33.1%).
- Per Business Quant data, AMLX's Share-based Compensation in the three quarters before Q2 2026 was $6.12 million (Q1 2026), $6.39 million (Q4 2025) and $7.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | 8.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.32 Mn |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 6.39 Mn |
| Sep 30, 2025 | 7.08 Mn |
| Jun 30, 2025 | 7.35 Mn |
| Mar 31, 2025 | 6.83 Mn |
| Dec 31, 2024 | 6.74 Mn |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 9.57 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 9.53 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 9.95 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 6.09 Mn |
| Sep 30, 2022 | 5.52 Mn |
| Jun 30, 2022 | 5.71 Mn |
| Mar 31, 2022 | 4.39 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 802,000.00 |
API Access
Amylyx Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();